Showing 2,621 - 2,640 results of 3,265 for search '"hematology"', query time: 0.10s Refine Results
  1. 2621
  2. 2622
  3. 2623
  4. 2624
  5. 2625
  6. 2626
  7. 2627
  8. 2628

    Assessment of Body Composition, Bone Density, and Biochemical Markers of a Natural Bodybuilder During Contest Preparation by Konstantinos Michailidis, Nikolaos Zaras, Dimitrios Balampanos, Alexandra Avloniti, Theodoros Stampoulis, Maria Protopapa, Dimitrios Pantazis, Nikolaos-Orestis Retzepis, Ilias Smilios, Athanasios Chatzinikolaou

    Published 2024-12-01
    “…At the beginning (W31), in the middle (W18), and one week before the contest (W1), measurements included body composition via DEXA, testosterone and cortisol hormonal concentrations, and lipid, blood, and liver biochemical markers via an automated hematology analyzer. A gradual decrease in energy intake (−27.6%) and increased daily activity (169.0%) was found. …”
    Get full text
    Article
  9. 2629

    Prevalence of carbapenemase-encoding genes carriage in patients admitted to multidisciplinary hospital in Moscow by Ni O.G., Shifman E.M., Yakovlev S.V., Bykov A.O., Gorbacheva A.A., Kruglov A.N., Belotserkovskiy B.Z., Matyushkov N.S., Galata A.A., Protsenko D.N.

    Published 2024-09-01
    “…The carriage rate was the highest among patients from therapeutic wards (17.5%) and the lowest in patients from hematology wards (3.0%). Conclusions. Our study is one of the first in Russia to evaluate the prevalence of community-acquired carriage of carbapenemase genes. …”
    Get full text
    Article
  10. 2630
  11. 2631
  12. 2632
  13. 2633
  14. 2634
  15. 2635

    Serum Lactate Dehydrogenase Is a Novel Predictor for the Severity in the Patients With MAFLD: A Cross-Sectional Study in Hefei, China by Yu L, Bao S, Zhu F, Xu Y, Zu F, Liu Y, Jiang R, Chen S, Chen W

    Published 2025-02-01
    “…MAFLD was defined as the presence or absence of fatty liver disease as suggested by histologic biopsy of liver or postoperative pathology slides, or even hematology, and meets one of the following three conditions: overweight or obesity, T2DM, and metabolic dysfunction (MetS). …”
    Get full text
    Article
  16. 2636
  17. 2637
  18. 2638
  19. 2639
  20. 2640